These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6856953)

  • 21. [New data on monoamine oxidase inhibitors].
    Gorkin VZ
    Vestn Akad Med Nauk SSSR; 1971; 26(11):23-8. PubMed ID: 4942003
    [No Abstract]   [Full Text] [Related]  

  • 22. Biogenic amines in the developing brain.
    Eiduson S
    UCLA Forum Med Sci; 1971; 14():391-418. PubMed ID: 4399509
    [No Abstract]   [Full Text] [Related]  

  • 23. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase.
    Naoi M; Matsuura S; Parvez H; Takahashi T; Hirata Y; Minami M; Nagatsu T
    J Neurochem; 1989 Feb; 52(2):653-5. PubMed ID: 2911035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on brain metabolism of biogenic amines.
    Schacht U; Leven M; Bäcker G
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):77S-87S. PubMed ID: 199222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery.
    Lang W; Masucci JA; Caldwell GW; Hageman W; Hall J; Jones WJ; Rafferty BM
    Anal Biochem; 2004 Oct; 333(1):79-87. PubMed ID: 15351283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of MAO inhibitors on the high-affinity reuptake of biogenic amines in rat subcortical regions.
    Tekes K; Magyar K
    Neurobiology (Bp); 2000; 8(3-4):257-64. PubMed ID: 11225517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of catalytic properties of mink and rat liver monoamine oxidase].
    Iagodina OV
    Zh Evol Biokhim Fiziol; 2008; 44(6):570-6. PubMed ID: 19198157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of monoamine oxidases. Inhibition of bovine brain MAO in intact mitochondria by selective inhibitors.
    Achee FM; Gabay S
    Biochem Pharmacol; 1977 Sep; 26(17):1637-44. PubMed ID: 901582
    [No Abstract]   [Full Text] [Related]  

  • 30. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-methyl-norsalsolinol, a putative dopaminergic neurotoxin, passes through the blood-brain barrier in vivo.
    Thümen A; Behnecke A; Qadri F; Bäuml E; Thümen A; Behnecke CA; Qadri F; Bäuml E; Moser A
    Neuroreport; 2002 Jan; 13(1):25-8. PubMed ID: 11924888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
    Jensen SB; Olsen AK; Pedersen K; Cumming P
    Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of dimethylnitrosamine metabolism by some heterocyclic compounds and by substrates and inhibitors of monoamine oxidase in the rat.
    Phillips JC; Bex C; Lake BG; Cottrell RC; Gangolli SD
    Cancer Res; 1982 Sep; 42(9):3761-5. PubMed ID: 7105041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some properties of monoamine oxidase.
    Tipton KF
    Adv Biochem Psychopharmacol; 1972; 5():11-24. PubMed ID: 5054202
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of chlorpromazine, imipramine and lithium on MAO-A and MAO-B activity in rat brain mitochondria.
    Nag M
    Indian J Exp Biol; 2004 Sep; 42(9):941-4. PubMed ID: 15462192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway.
    Coatrieux C; Sanson M; Negre-Salvayre A; Parini A; Hannun Y; Itohara S; Salvayre R; Auge N
    Free Radic Biol Med; 2007 Jul; 43(1):80-9. PubMed ID: 17561096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain.
    Kohno M; Ohta S; Hirobe M
    Biochem Biophys Res Commun; 1986 Oct; 140(1):448-54. PubMed ID: 3778459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemistry and physiology of monoamine oxidase (MAO) activity in the ring dove (Streptopelia risoria). I. Characteristics of MAO activity in vitro.
    Hall TR; Lea RW; Vowles DM; Harvey S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(2):417-22. PubMed ID: 2866915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pargyline effect on luteinizing hormone secretion throughout the rat estrous cycle: correlation with serotonin, catecholamines and nitric oxide in the medial preoptic area.
    Lima FB; Szawka RE; Anselmo-Franci JA; Franci CR
    Brain Res; 2007 Apr; 1142():37-45. PubMed ID: 17303090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.